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Abstract
In Indonesia, the incidence rate (IR) of dengue fever reported increase almost in every 
year since the first cases were found in 1968, from 0.05 to ~35–40 per 100,000 population 
in 2013, with superimposed epidemics demonstrating a similar increasing trend with 
the highest epidemic occurring in 2010 (IR 85.7). Most currently, about 80% of regencies/
cities had been infected and posed as very high vulnerability of spreading the disease. 
Increased incidence of dengue fever is associated with the increase of rainfall and tem-
perature in particular years. Up to the year of 2038, a climate model of Meteorological, 
Climatological, and Geophysical Agency shows increasing trend of rainfall and tem-
perature. Along with its unsuccessful of Indonesia dengue fever control program will 
lead challenges to reduce dengue fever endemic in the future. Revitalization of dengue 
disease control program in every single stage with close monitoring implementation is 
urgently needed. Socialization, community capacity building, and participation could 
also be a joint sectoral action to enhance the dengue fever control program.
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1. Introduction
Dengue fever is a mosquito-borne disease caused by any one of four closely related dengue 
viruses (DenV-1, DenV-2, DenV-3, and DenV-4). Dengue fever is transmitted by the bite of an 
Aedes mosquito infected with a dengue virus. The female mosquito becomes infected when it 
bites a person with dengue virus in their blood both indoors and outdoors during the daytime 
(from dawn to dusk). Aedes aegypti is particularly involved, as it prefers to lay its eggs in 
artificial water containers, to live in close proximity to humans, and to feed on people rather 
than other vertebrates.
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
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distribution, and reproduction in any medium, provided the original work is properly cited.
Dengue infection is the most rapidly spreading mosquito-borne viral disease in the world. 
Infections are most commonly acquired in the urban environment. In recent decades, the 
expansion of villages, towns, and cities in the areas in which it is common and the increased 
mobility of people have increased the number of epidemics and circulating viruses. Dengue 
fever, which was once confined to Southeast Asia, has now spread to Southern China, coun-
tries in the Pacific Ocean and America, and might pose a threat to Europe. In the last 50 years, 
dengue virus infections had expanded to many other countries with significant increasing 
cases [1] up to 2.5 billion people living in endemic countries where about 1.8 billion (more 
than 70%) in Southeast Asia and the Western Pacific Region [1–4]. About 50 million dengue 
infections occur every year [2, 3], and approximately 500,000 patients are hospitalized of 
whom dominated by children [2–7]. The increasing incidence and geographical spread of den-
gue virus were more likely driven by demographic and societal changes such as population 
growth, urbanization, and modern transportation [8]. The traveler movement also contrib-
uted to the risk of contracting dengue disease from nonendemic countries to endemic dengue 
areas to nonendemic regions where competent mosquito vectors are currently found [9–12].
Indonesia, with 257.5 million inhabitants and 17,500 islands spread across the equator, 
poses as the largest archipelago country in the world [13], comprising 3.1 million km2 of 
ocean (62% of the total area) with a coastline of 81,000 km and approximately 2 million km2 
of land (38% of the total area). Its tropical climate and subsequent relative high humidity 
makes Indonesia favorable conditions for vector-borne disease transmission. The increasing 
trend of dengue infections over the current decades putting Indonesia as one of endemic 
area for dengue fever and tread both the people as well as travelers visiting the archipelago 
[14]. Its burden is a result of a constant ground of established infections in the past period, 
combined with epidemics of emerging infectious diseases (EID) [15]. This chapter describes 
the dengue fever status or situation in Indonesia, its vulnerability among population, the 
future challenges, and the disease prevention and control.
2. Dengue fever status in Indonesia
Indonesia is reported as the second largest with dengue fever cases among 30 endemic coun-
tries. The number of cases of dengue fever is most prevalent in the provinces of East Java, 
West Java, and Central Java. However, there are a number of provinces that are vulnerable 
with its high incidence rate of dengue fever. In 1968, the first 58 dengue cases were reported in 
Indonesia from the city of Jakarta (DKI Jakarta) and Surabaya (East Java) [16–19]. Since then, 
the sharp increasing numbers of cases and spreading to many other geographical locations 
have been reported [16, 17, 20–25]. The epidemiology of dengue fever in Indonesia has been 
described mostly in the form of case series, reporting on single outbreaks, or clinical and 
virological studies in confined geographical locations and selected years [26].
A study in 2014 reported that the annual dengue fever incidence increased from 0.05/100,000 in 
1968 to ~35–40/100,000 in 2013. The highest epidemic occurred in 2010 with the incidence of 
85.7/100,000 population. The data revealed declining of case fatality rate (CFR) from 41% in 
1968 to 0.73% in 2013. Dengue cases increased among ages during the observation period up 
to 1998 with the highest incidence of aged 5–14 years. From 1999 onward, the trend of dengue 
incidence increased among those aged 15 years or over. This study indicates incidence of 
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dengue fever increased rapidly over the past 45 years in Indonesia with peak incidence shift-
ing from young children to older age groups [27].
The threat of dengue fever among children was emphasized clearly on a recently published 
study among 3194 children aged 1 through 18 years who lived in 30 different urban neigh-
borhoods. Children blood samples were drawn for antibodies to dengue, an indication that 
someone has been infected with the virus in the past, and found that 69.4% of all children 
tested positive for dengue antibodies. Among the age groups, positive antibodies found 
33.8% at the group of 1–4 year olds, 65.4% at the group of 5–9 year olds, 83.1% at the group 
of 10–14 year olds, and 89% at the group of 15–18 year olds. The first time to become infected 
with dengue was at the age of 4.8 years as the median, and in addition, 13.1% of children on 
average get their first dengue infection each year. It was also found that the more people in 
a household who had been diagnosed with dengue since a child’s birth, the more likely the 
child were to test positive for dengue antibodies [28].
The incidence rate (IR) for every 100,000 population in seven provinces were found over 100 
or are prone to dengue cases. The seven provinces are Bali (484), East Kalimantan (306), DKI 
Jakarta (198.7), DI Yogyakarta (167.9), North Kalimantan (158.3), Southeast Sulawesi (123.3), 
and South Kalimantan (101.1). The lowest IR is achieved by Papua province (11.8) and West 
Kalimantan (12.1) (Figure 1). The whole of Indonesia is high (IR is 78.0). In general, the 
increasing number of dengue fever cases is more likely followed by the spread of the cities 
Figure 1. Incidence rate (IR) of dengue fever per 100,000 population by province in Indonesia 2016 (source: DG of CDC 
MOH 2017).
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Figure 2. Incidence rate (IR) of dengue disease per 100,000 population and number of cities/districts infected in Indonesia 
1968–2016.
and districts infected in all of 34 provinces in Indonesia (Figure 2). From the total of 497 cities 
and districts in Indonesia, about 80% have reported the dengue fever cases in 2017.
In the context of dengue fever mortality, as many as 1229 people died in 2015 from the disease 
caused by this dengue virus. Throughout the history of dengue fever in Indonesia, the highest 
death rate occurred when first time the disease was discovered in 1968 in Surabaya. Of the 
58 people infected, 24 lives were lost. In 2016, the highest percentage of CFR was obtained in 
Maluku Province (6.0%), Gorontalo (6.1%), and West Papua (4.6%). Provinces with the lowest 
CFR were achieved by Papua (0%), DKI Jakarta (0.1%), and NTT (0.2%). In some provinces, 
dengue disease was an outbreak in 1998 and 2004 that caused 79,480 people and 800 more 
deaths. In subsequent years, there has been reported a decrease in the case of death but note 
that the number of cases continues to increase. In 2008, there were 137,469 cases and 1187 
deaths. In 2009, there were 154,855 cases and 1384 deaths [29].
3. Dengue fever vulnerability
Studies on Indonesian vulnerability to climate change were mostly focused on mitiga-
tion aspects, such as water scarcity, reduction emission from deforestation and degradation 
(REDD), the forest conservations, disasters, land drought, floods, and others. Meanwhile, the 
vulnerability study on adaptation is still rare, especially to human health. In 2013, Research 
Center for Climate Change—University of Indonesia (RCCC-UI) initiated a study on vulner-
ability of dengue disease to climate change/variability in collaboration with the Directorate of 
Environmental Health of the Ministry of Health and supported by Indonesia Climate Change 
Trust Fund (ICCTF). The study involved 20 districts/cities in 5 provinces namely West Sumatra, 
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Jakarta, East Java, Bali, and Central Kalimantan which were selected based on the availability 
of monitoring station of the Indonesian Agency for Meteorology, Climatology, and Geophysics 
(BMKG). The dengue disease vulnerability components were generated based on bionomic 
mosquito and habitat, pathology dengue disease, and factors related to dengue disease occur-
rence. The exposure variables include land use (settlement, offices, business, schools, etc.) and 
population density. The sensitivity variables include breeding places and resting areas of Aedes 
mosquitoes, pupa and adult density, incidence of dengue fever, and population mobility. The 
adaptive capacity variables include availability of health services (number of hospitals, clin-
ics, and public health centers), treatment management and skilled providers, implementation 
of dengue fever intervention program, community participation and involvement on dengue 
fever prevention program, and personal protection behavior. The Intergovernmental Panel 
Convention for Climate Change (IPCC) vulnerability analysis was implemented to gain the 
coping range index of DF for each city/district [31]. The coping range index (CRI) = 1 (blue) 
indicates the people vulnerability of having dengue fever is very low and located at quadrant 
between low exposure and sensitivity index and high adaptive capacity index; CRI = 2 (green) 
indicates the people vulnerability of having dengue fever is low and located at quadrant 
between high exposure and sensitivity index and high adaptive capacity index; CRI = 3 (yellow) 
indicates the people vulnerability of having dengue fever is medium and located at quadrant 
between medium exposure and sensitivity index and medium adaptive capacity index; CRI = 4 
(brown) indicates the people vulnerability of having dengue fever is high and located at quad-
rant between low exposure and sensitivity index and low adaptive capacity index; and CRI = 5 
(red) indicates the people vulnerability of having DF is very high and located at quadrant 
between high exposure and sensitivity index and low adaptive capacity index (Figure 3) [30].
A study of Research Center for Climate Change—Universitas Indonesia 2013–2014 reported that 
in almost all districts/municipalities under study (in 17 out of 20 regencies/cities) indicated a 
very serious vulnerability condition of very high coping range index (CRI) (red = 5) since 2005. 
Figure 3. The coping range index (CRI) of dengue disease vulnerability.
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Figure 4. Map of CRI of dengue fever vulnerability in Jakarta/Banten and West Sumatra in 2012.
Figure 5. Map of CRI of dengue fever vulnerability in Bali, Central Kalimantan, and East Java in 2012.
Very high CRI was found in 75% of regencies/cities in West Sumatra province (City of Padang 
in 2005, 2007, 2008, 2009, and 2012; Padang Pariaman Regency in 2008, 2011, and 2012; and City 
of Padang Panjang in 2007 and 2008), all of regencies/cities in Bali province (City of Denpasar in 
2006, 2009, and 2010; Jembrana Regency in 2007; City of Badung in 2007, 2009, and 2010), 80% 
of regencies/cities in East Java province (City of Surabaya in 2007, 2008, 2009, 2011, and 2012; 
Malang Regency in 2007, 2008, 2009, 2011, and 2012; City of Pasuruan in 2007, 2008, 2009, 2010, 
and 2011; Sumenep Regency in 2007, 2008, 2009, 2011, and 2012), all of cities in Jakarta province 
(City of Central Jakarta in 2005, 2006, 2007, 2008, 2009, and 2012; City of North Jakarta in the year 
2006–2012), half of cities in Banten province (City of Tangerang in 2007–2012), all of regencies/cit-
ies in Central Kalimantan province (City of Palangkaraya in 2006, 2008, and 2012; Kotawaringin 
Barat Regency in 2005–2008 and in 2012; Kotawaringin Timur Regency in 2008, 2010, and 2011; 
Barito Utara Regency in 2008). High CRI (brown = 4) was also happened more often before 
and following the years of the very high CRIs occurrences in the regencies/cities [30]. Thus, this 
concluded that dengue fever is in the level of seriously vulnerable to people living in the regen-
cies/cities under study in Indonesia. Figures 4 and 5 show the dengue fever vulnerability among 
cities/districts in 2012 in the provinces of Jakarta/Banten, Bali, Central Kalimantan, and East Java.
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4. Dengue fever challenges
Dengue emerged as a public health burden and has become increasingly important, with 
progressively longer and more cyclical epidemics of dengue including cases of dengue with 
alarm signs and severe dengue. In Indonesia, although some programs and control efforts 
have been performed, both the incidence and case fatality rate are still high and not showing 
significant changes. There are still some challenges that need to be handled, such as sur-
veillance system, availability adequate laboratory, community knowledge, awareness, and 
involvement against dengue, many new cases reported from new city or district, high mobil-
ity of dengue fever’s carrier, density of community in the city/district central, access to health 
centers, and the availability of drugs and vaccines.
Surveillance for this vector-borne viral disease remains largely passive and based on the hos-
pital report which is the estimation of real cases still underreported. It was also reported 
that many health centers and clinics were without adequate laboratory support. This will 
lead increasing of referral activities to hospitals with the consequences of time spent and 
transportation challenges in rural areas. Some studies found about one-third adult popula-
tion with sufficient knowledge about dengue fever and its fast spreading to other people. 
However, only about 17% of them aware and clearly know the way for prevention [31, 32]. In 
addition, the high number of dengue fever incidence can also be caused by increasing Aedes 
aegypti mosquito breeding places, mosquito habitat, more effective mode of transmission, 
more frequent dengue fever course, shorten dengue fever symptoms, access for dengue fever 
treatment. Home conditions such as governance and the layout of goods at home can also 
affect the high number of dengue fever incidence.
Indonesia is a country with a vast region, varied geographic and biodiversity, populated den-
sity, and characteristics of various populations. In the last decade, several new administration 
districts developed with the newly reporting and recording management systems. This will 
lead underreporting of dengue fever both from the passive surveillance and the number of 
real cases estimation. The increasing number of people and the area of dengue fever spread 
in Indonesia is due to the high population mobility, the development of urban areas, cli-
mate change, increasing population density, and changes in population distribution. Climate 
change causes changes in rainfall, temperature, humidity, and air direction thus affecting the 
breeding of Aedes aegypti mosquitoes.
The last and most important thing of the challenges is community participation. The participa-
tion of the community to participate consistently to keep the environment from dengue is still 
difficult. Various breakthroughs by government such as 3 M plus (draining, covering, burying 
or utilizing/recycling and all forms of prevention, such as to apply powder of larvae-killers in 
water tanks, to use mosquito repellents, to keep fish predators to consume mosquito larvae, 
etc.) movement, Jumantik (volunteer or student who periodically monitor Aedes larvae on 
water storages at home) and so have long been circulated. But people who forget and bored 
easily become a problem. For example, after some time, there was no extraordinary incident, 
the community considered it safe and careless, consequently when the case exploded, people 
just reacted [33].
Among other challenges, passive surveillance systems tend to underestimate the burden of 
communicable diseases such as dengue. By utilizing the data from the Indonesian surveillance 
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Figure 6. Estimated annual number of dengue cases and hospitalizations in Indonesia following adjustment of 
surveillance reports with EFs, and their 95% confidence intervals (CIs), 2006–2015.
system and associated health system parameters, a study to estimate the proportion of dengue 
was conducted by Delphi panel in 2017. The iterative estimation was generated by calculat-
ing the expansion factors (EF), the ratio of total and reported cases during the presentation 
of medical and epidemiological data and subsequent discussions. The data revealed that 
from all of symptomatic Indonesian dengue episodes, 57.8% enter healthcare facilities to 
seek treatment but only 39.3% of them are diagnosed as dengue. Furthermore, only 20.3% of 
them are subsequently reported in the surveillance system. Public sector found dominating 
occurrence of hospitalizations and followed by private sector for ambulatory episodes (∼55%). 
Therefore, estimations gave an overall EF of 5.00; hospitalized EF of 1.66; and ambulatory EF 
of 34.01 which, when combined with passive surveillance data, equates to an annual average 
(2006–2015) of 612,005 dengue cases, and 183,297 hospitalizations (Figure 6.). The findings are 
lower than those similar estimations published elsewhere, perhaps due to case definitions, 
local clinical perceptions, and treatment-seeking behavior [34].
5. Dengue fever prevention and control
The goal of WHO Global Strategy is to reduce the burden of dengue. Its specific objectives 
are: (1) to reduce dengue mortality by at least 50% by 2020, (2) to reduce dengue morbidity 
by at least 25% by 2020, and (3) to estimate true burden of the disease by 2015 (the year 2010 
is used as the baseline). The implementing strategy is expected to pave the way for reduc-
ing dengue morbidity and mortality nationwide through strengthening local and national 
capabilities, as well as regional coordination. National Dengue Control Program in Indonesia 
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is currently implementing WHO Global Strategy 2012–2020 that promotes coordination and 
collaboration among multisectoral partners, an integrated vector management approach and 
sustained control measures at all levels. Dengue is an ecological disease, therefore coordi-
nation and collaboration by all sectors within the government, communities, civil societ-
ies, private sectors, and media need to be strengthened. All sectors should harmonize the 
prevention, surveillance (entomological and epidemiological), and case management with 
the existing health systems, in order to make the program sustainable, cost-effective, and 
ecologically sound.
It has long been believed that preventing and reducing dengue virus transmission was very 
depended upon vectors control (Aedes sp.) or interrupt the human-vector contact. Activities 
to control transmission should target Ae. aegypti (the main vector) in the habitats of its adult 
stages as well as the immature. The high death toll from dengue fever demands people to 
stay alert to possible outbreaks of this disease in their neighborhoods [35]. Therefore, it is 
important for the community to collectively jointly create a healthy environment free of larvae 
to suppress the incidence of dengue disease. The prevention and control programs need to 
be undertaken with specific commitments from stakeholders from the top to the bottom lev-
els. Currently, the Ministry of Health has launched a program of Nest Mosquito Eradication 
Program (PSN) through 3 M plus way.
6. Conclusion
Given the wide area in the tropical temperature, high population density in urban area, and 
various geographic and biodiversity, putting Indonesia as a natural potential for the habitat 
of dengue viruses. The number of dengue fever cases reported dramatically increases since 
it was firstly found in 1968 and spread out almost in 80% cities and districts in Indonesia in 
2016. Many of those cities and districts were very vulnerable and putting million people at 
risk to the disease in 2012. Some challenges are still heading in the front of the prevention and 
control implementation actions. However, keeping spirit for struggling to combat dengue 
fever in Indonesia along with full commitment and involvement of community are urgently 
needed as well as to revitalize dengue disease eradication programs at every stage with close 
monitoring implementation.
In addition, technical guidance and increased skills of health officers are indispensable. 
Socialization of a hands-on program activities in particular and increased capacity and active 
participation of community on the action could be a joint action in preventing the increase in 
dengue disease associated to climate change.
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